Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Greeley, CO MSA — September 2026
Greeley life sci pay climbs as Colorado's broader market cools.
Validation Engineer advertised pay hit $120,500 locally against $108,377 nationally even as Colorado logged its third straight month of job losses and 4.0% unemployment.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Colorado unemployment rate: 4.0% — Up from 3.8%, 3rd straight monthly job loss
- Validation Engineer advertised pay: $120,500 — vs $108,377 national median
- Colorado avg weekly wage growth: 5.4% YoY — 8th nationally, Q1 2026
- Greeley MSA nonfarm employment: 117.4K — Essentially flat since Sept 2025
Key takeaways
Validation Engineer pay is outrunning the national market.
Metro median advertised pay of $120,500 sits well above the $108,377 national figure, a gap consistent with Colorado's manufacturing-pipeline buildout and Weld County's concentration of production and quality roles. Employers benchmarking against national data alone risk underpricing this role locally.
Clinical Research Associate pay signals a tightening local market.
Metro median advertised pay of $98,381 runs roughly 8% above the national $90,956 figure, both trending up significantly. Colorado's tight overall labor market (4.0% unemployment, third straight month of job losses) appears to be compressing supply for credentialed clinical roles even as general hiring slows.
Manufacturing build-out may outpace available specialized labor.
Colorado BioScience Institute's projection of 218+ entry-level manufacturing openings across 13 employers signals a regional preference for in-house production capacity, but this expansion lands in a metro where total nonfarm employment hasn't grown meaningfully since September 2025. Leaders planning internal manufacturing headcount should stress-test timelines against actual local talent availability, not statewide projections.
Statewide wage growth hides function-level divergence.
Colorado's 5.4% year-over-year average weekly wage growth (8th nationally) is a composite figure that likely understates pressure in regulatory and CMC roles, where national director-level compensation already reaches $520K for scarce specialties like cell/gene CMC. Compensation benchmarking built on broad state or metro averages may materially misprice mission-critical life sci roles.
Median advertised pay by role — Greeley, CO MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $84,500 | $115,420 | $142,919 | Significant increase | $131,354 |
| Clinical Research Associate * | $75,864 | $98,381 | $108,168 | Significant increase | $90,956 |
| Lab Technician * | $43,134 | $47,327 | $52,000 | Stable | $47,402 |
| Regulatory Affairs Specialist * | $70,754 | $104,796 | $117,527 | Moderate decline | $104,000 |
| Clinical Data Manager * | $94,840 | $117,810 | $123,978 | Stable | $123,031 |
| Biostatistician * | $109,970 | $129,334 | $158,127 | Stable | $133,322 |
| Validation Engineer * | $105,678 | $120,500 | $155,517 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Weld County's labor market continues to reflect Colorado's broader cooling trend, with the state's third consecutive monthly job loss in August and unemployment climbing to 4.0% even as manufacturing, transportation and healthcare remain Greeley's structural strengths. Tighter statewide labor force growth, driven by slower in-migration, is colliding with specialized life sci hiring needs in a metro where nonfarm employment has essentially flatlined near 117,000 jobs since late 2025.
What it means
Flat headcount growth across Greeley's broader economy masks a bifurcated reality for life sci employers: generalist roles face ample local supply, while clinical, regulatory, CMC and quality positions compete against statewide scarcity and a 20% biotech-over-research-scientist pay premium documented across Colorado. Build-vs-outsource calculus shifts further toward CDMO/CRO partnerships for non-core functions as specialized in-house hiring becomes slower and costlier, while local advertised pay for Validation Engineer ($120,500 metro median, up significantly) signals manufacturing-adjacent roles are already pricing in scarcity. Consider reviewing whether current headcount plans for quality and regulatory functions assume a labor supply that no longer exists in this metro.
Looking ahead
Worth watching: Colorado's third consecutive month of statewide job losses raises the question of whether Weld County's relatively stable manufacturing and healthcare base will continue to diverge from the broader state slowdown, or begin to feel it by Q4.
Emerging pressure point: Colorado BioScience Institute's 218+ projected manufacturing openings will test whether Greeley-area employers can fill entry-level production roles locally or must recruit from Denver-Boulder or out of state, with direct implications for relocation incentives and wage premiums.
Early indicator: National September layoff announcements at BioMarin (117 roles) and Bristol Myers (265 roles) concentrate in consolidation functions, not execution-critical roles; watch whether any displaced regulatory, quality or CMC talent surfaces in the Colorado candidate pool over the next two months.
Potential inflection point: Colorado's statewide 1.5 job openings per job seeker ratio suggests continued candidate leverage in specialized roles; a shift toward parity would materially change retention risk calculus for CRA, regulatory and CMC positions across Northern Colorado employers.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.